Cargando…
Phosphorus-32 interstitial radiotherapy for recurrent craniopharyngioma: Expressions of vascular endothelial growth factor and its receptor-2 and imaging features of tumors are associated with tumor radiosensitivity
To investigate the relationship of the expression of vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor-2 (VEGFR-2) and imaging features with the therapeutic efficacy of Phosphorus-32 colloid interstitial radiotherapy in recurrent craniopharyngioma. Thirty-two pati...
Autores principales: | Hu, Chenhao, Chen, Jinhui, Meng, Yuhong, Zhang, Jianning, Wang, Yaming, Liu, Rui, Yu, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242301/ https://www.ncbi.nlm.nih.gov/pubmed/29952957 http://dx.doi.org/10.1097/MD.0000000000011136 |
Ejemplares similares
-
Drug distribution and clinical safety in treating cystic craniopharyngiomas using intracavitary radiotherapy with phosphorus-32 colloid
por: Chang, Hongbo, et al.
Publicado: (2018) -
Treatment of Cystic Craniopharyngioma with Intracystic Stereotactic Instillation of Phosphorus 32
por: Shahzadi, Sohrab, et al.
Publicado: (2017) -
Remote delayed recurrence of craniopharyngioma after radiotherapy
por: Balasubramaniam, Chidambaram, et al.
Publicado: (2015) -
Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
por: Burgess, Laura, et al.
Publicado: (2020) -
Biomimetic radiosensitizers unlock radiogenetics for local interstitial radiotherapy to activate systematic immune responses and resist tumor metastasis
por: Zhang, Jiajia, et al.
Publicado: (2022)